PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia.\', \'Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center (IRCCS), Rozzano, Milan, Italy.\', \'Dermatology, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy; Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Milan, Italy.\', \'Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, CA, USA.\', \'Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, CA, USA. Electronic address: megershwin@ucdavis.edu.\', \'Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center (IRCCS), Rozzano, Milan, Italy; Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Milan, Italy. Electronic address: carlo.selmi@hunimed.eu.\', \'Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia. Electronic address: juan.anaya@urosario.edu.co.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0896-8411(20)30128-110.1016/j.jaut.2020.102506
?:hasPublicationType
?:journal
  • Journal of autoimmunity
is ?:pmid of
?:pmid
?:pmid
  • 32563547
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.046
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • Autoinflammatory and autoimmune conditions at the crossroad of COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all